HIA
GSK icon

Harbor Investment Advisory’s GSK GSK Stock Holding History

Harbor Investment Advisory’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-109
Closed -$5.34K – 1280
2025
Q4 		$5.34K Hold
109
– – ﹤0.01% 1040
2025
Q3 		$4.7K Hold
109
– – ﹤0.01% 1013
2025
Q2 		$4.19K Hold
109
– – ﹤0.01% 1014
2025
Q1 		$4.22K Hold
109
– – ﹤0.01% 1000
2024
Q4 		$3.69K Buy
109
+9
+9% +$324 ﹤0.01% 1001
2024
Q3 		$4.09K Hold
100
– – ﹤0.01% 1004
2024
Q2 		$3.85K Sell
100
-12
-11% -$505 ﹤0.01% 1001
2024
Q1 		$4.8K Buy
112
+8
+8% +$330 ﹤0.01% 980
2023
Q4 		$3.85K Hold
104
– – ﹤0.01% 974
2023
Q3 		$3.77K Sell
104
-222
-68% -$7.88K ﹤0.01% 959
2023
Q2 		$11.6K Buy
326
+105
+48% +$3.77K ﹤0.01% 999
2023
Q1 		$7.86K Buy
221
+22
+11% +$770 ﹤0.01% 1060
2022
Q4 		$6.99K Buy
199
+69
+53% +$2.3K ﹤0.01% 1065
2022
Q3 		$4K Hold
130
– – ﹤0.01% 1159
2022
Q2 		$7K Sell
130
-456
-78% -$25.2K ﹤0.01% 1095
2022
Q1 		$32K Hold
586
– – ﹤0.01% 844
2021
Q4 		$32K Hold
586
– – ﹤0.01% 848
2021
Q3 		$28K Hold
586
– – ﹤0.01% 888
2021
Q2 		$29K Hold
586
– – ﹤0.01% 840
2021
Q1 		$26K Sell
586
-36
-6% -$1.63K ﹤0.01% 837
2020
Q4 		$29K Sell
622
-36
-5% -$1.65K ﹤0.01% 753
2020
Q3 		$31K Sell
658
-180
-21% -$9.02K 0.01% 632
2020
Q2 		$43K Hold
838
– – 0.01% 470
2020
Q1 		$40K Buy
838
+180
+27% +$9.6K 0.01% 443
2019
Q4 		$39K Buy
+658
New +$36.6K 0.01% 454

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Harbor Investment Advisory's GSK Position: Q1 2026 in Review

Harbor Investment Advisory sold out of GSK (GSK) in Q1 2026, closing a stake of 109 shares — an estimated $5.34K sold.

Harbor Investment Advisory first reported a position in GSK in Q4 2019 and held it in 25 quarters. The position peaked at $43K in Q2 2020. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Harbor Investment Advisory reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Harbor Investment Advisory sold 109 GSK shares in Q1 2026, an estimated $5.34K.
  • Harbor Investment Advisory first reported a position in GSK in Q4 2019 and held it in 25 quarters.
  • Harbor Investment Advisory's GSK position peaked at $43K in Q2 2020.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Harbor Investment Advisory's 13F filing for Q1 2026, filed 23 Apr 2026.